Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Triangle Compounding Pharmacy Inc
483
•Triangle Compounding Pharmacy Inc•September 22, 2014

Triangle Compounding Pharmacy Inc – FDA 483, Sep 22, 2014

Record Details

An FDA 483 document was issued to Triangle Compounding, an outsourcing facility located in Cary, NC, following an inspection conducted from September 8 to September 22, 2014. The inspection revealed several critical deficiencies indicating non-compliance with federal drug manufacturing regulations and specific requirements for outsourcing facilities.

Main violations included a systematic failure to thoroughly investigate sterility failures, with inadequate root cause analysis and a lack of implemented corrective actions to prevent reoccurrence. Complaint records were found to be deficient, as investigations into adverse drug experiences were not comprehensively conducted or evaluated for potential MedWatch reporting. The facility also failed to adhere to procedures designed to prevent microbiological contamination, specifically lacking routine microbial sampling of personnel gowning during sterile product processing.

Further issues comprised insufficient laboratory controls, such as the absence of training for 100% visual inspection of sterile products and a lack of established methods to evaluate preservative effectiveness. Triangle Compounding accepted component supplier analyses without validating their reliability and did not follow its written stability testing program for sterile drug products. Additionally, there was an absence of written procedures for the management of labeling and packaging materials, and drug product labels were non-compliant with section 503B(a)(10)(A)&(B), missing crucial information like inactive ingredient lists and adverse event reporting details. The company is required to implement comprehensive corrective actions to address all observations and achieve full compliance with federal regulations governing sterile drug manufacturing and labeling.

Company
Triangle Compounding Pharmacy Inc
Inspection date
September 22, 2014
Product type
Drugs
Office
Atlanta District Office
People
  • Bonita S. Chester (Director of Inspection Readiness)
  • Tomika L. Bivens (Investigator)
View Company Profile

ID · f6df6829-2546-4e9d-be13-48822c2a0d92

Violation Codes6
21 U.S.C. 324(a)(4)FD&C Act 905(j)21 CFR 21021 CFR 211FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Triangle Compounding Pharmacy Inc
  • 483 - 2019-04-04April 4, 2019
  • 483 - 2017-07-13July 13, 2017
  • 483 - 2015-01-16January 16, 2015
  • 483 - 2013-03-01March 1, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Triangle Compounding Pharmacy Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.